Study shows that bedtime regularity predicts CPAP compliance

May 7, 2013, American Academy of Sleep Medicine

A new study suggests that regularity of bedtime prior to initiation of continuous positive airway pressure (CPAP) therapy is an important factor that may influence treatment compliance in adults with obstructive sleep apnea (OSA).

Results show that bedtime variability was a significant predictor of CPAP adherence, which was defined as four or more hours of treatment use per night. The odds of one-month CPAP non-adherence were 3.7 times greater for every one unit increase in habitual, or pre-treatment, bedtime variability.

"Long-term use of CPAP, such as after the first month or longer, requires regular routines that are conducive to establishing a new ," said principal investigator Amy M. Sawyer, PhD, RN, assistant professor at Penn State University School of Nursing in University Park, Pa."

The research abstract was published recently in an online supplement of the journal , and Sawyer will present the findings Wednesday, June 5, in Baltimore, Md., at SLEEP 2013, the 27th annual meeting of the Associated Professional Sleep Societies LLC.

The study group comprised 97 adults with newly diagnosed OSA. Bedtime variability was derived from a seven-day sleep diary completed by each participant before CPAP treatment and one-month CPAP adherence was based on objective data collected from each CPAP device.

According to the authors, the study was not designed to test the effect of bedtime consistency on CPAP use. However, the results do suggest that regularity of bedtime may be a new opportunity for health scientists and to address the problem of non-adherence to CPAP.

"Our results suggest that CPAP use is associated with stable bedtime schedules," said Sawyer. "By stabilizing bedtime schedules, or promoting consistency in patterns and routines prior to initiating CPAP treatment, adherence may improve."

The American Academy of Sleep Medicine reports that obstructive is a common sleep illness affecting at least four percent of men and two percent of women. It involves repetitive episodes of complete or partial upper airway obstruction occurring during sleep despite an ongoing effort to breathe. The most effective option for OSA is CPAP therapy, which helps keep the airway open by providing a stream of air through a mask that is worn during sleep.

Explore further: Innovative approaches help sleep apnea sufferers benefit from CPAP

More information: Abstract: "Sleep schedule and CPAP adherence: Is regularity of pre-treatment bedtime influential on CPAP adherence?"

Related Stories

Innovative approaches help sleep apnea sufferers benefit from CPAP

December 1, 2011
People with obstructive sleep apnea are more likely to stick to prescribed treatment when a partner or parent is involved with their treatment, according to a team of sleep researchers.

CPAP found to improve sexual function, satisfaction in men with sleep apnea

June 13, 2012
Men who suffer from obstructive sleep apnea (OSA) are seeing another potential benefit from continuous positive airway pressure therapy, or CPAP: improved sexual function and satisfaction in non-diabetic men under age 60.

2.5 hours of patient/therapist contact time increases CPAP use

October 22, 2012
Although continuous positive airway pressure (CPAP) is often used as therapy for obstructive sleep apnea (OSA), patient compliance with CPAP remains an issue.

CPAP improves work productivity for sleep apnea patients

April 10, 2013
Continuous positive airway pressure is effective at increasing work productivity, according to a new study.

Recommended for you

Synthetic cannabinoid reduces sleep apnea

November 29, 2017
A synthetic version of a molecule found in the cannabis plant was safe and effective in treating obstructive sleep apnea in the first large, multi-site study of a drug for the sleep disorder funded by the National Institutes ...

Sleeping through the snoring: Researchers identify neurons that rouse the brain to breathe

November 2, 2017
A common and potentially serious sleep disorder, obstructive sleep apnea affects at least one quarter of U.S. adults and is linked to increased risk of diabetes, obesity and cardiovascular disease. In a paper published today ...

Remede system approved for sleep apnea

October 9, 2017
(HealthDay)—The Remede sleep system, an implanted device that treats central sleep apnea by activating a nerve that sends signals to the diaphragm to stimulate breathing, has been approved by the U.S. Food and Drug Administration.

Inflammation may precede sleep apnea, could be treatment target

September 1, 2017
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

More evidence: Untreated sleep apnea shown to raise metabolic and cardiovascular stress

August 31, 2017
Sleep apnea, left untreated for even a few days, can increase blood sugar and fat levels, stress hormones and blood pressure, according to a new study of sleeping subjects. A report of the study's findings, published in the ...

Sleep patterns contribute to racial differences in disease risk

August 18, 2017
Poor sleep patterns could explain, in part, the differences in the risk of cardiometabolic disease between African-Americans and European-Americans, according to a new study published in Proceedings of the National Academy ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.